{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:21:39Z","timestamp":1766157699661},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T00:00:00Z","timestamp":1385942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0080180","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T21:17:12Z","timestamp":1386019032000},"page":"e80180","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunolocalization of an Amino-Terminal Fragment of Apolipoprotein E in the Pick's Disease Brain"],"prefix":"10.1371","volume":"8","author":[{"given":"Troy T.","family":"Rohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey W.","family":"Catlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Rajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne W.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms","volume":"256","author":"KH Weisgraber","year":"1981","journal-title":"J Biol Chem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/475S20a","article-title":"Genetics: finding risk factors","volume":"475","author":"M Eisenstein","year":"2011","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/S0021-9258(18)68778-2","article-title":"Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains","volume":"263","author":"JR Wetterau","year":"1988","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"14908","DOI":"10.3390\/ijms140714908","article-title":"Proteolytic cleavage of apolipoprotein e4 as the keystone for the heightened risk associated with Alzheimer's disease","volume":"14","author":"TT Rohn","year":"2013","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.1434398100","article-title":"Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice","volume":"100","author":"FM Harris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons","volume":"98","author":"Y Huang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainres.2012.08.003","article-title":"Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain","volume":"1475","author":"TT Rohn","year":"2012","journal-title":"Brain Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1440-1789.2003.00523.x","article-title":"Pick body disease and Pick syndrome","volume":"23","author":"T Uchihara","year":"2003","journal-title":"Neuropathology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1440-1789.2006.00666.x","article-title":"Biochemistry and molecular biology of tauopathies","volume":"26","author":"M Hasegawa","year":"2006","journal-title":"Neuropathology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/978-1-4614-0653-2_23","article-title":"Pick's disease","volume":"724","author":"N Takeda","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/WAD.0b013e318199dd7d","article-title":"Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease","volume":"23","author":"A Feher","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0197-4580(00)00150-0","article-title":"Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease","volume":"21","author":"J Kalman","year":"2000","journal-title":"Neurobiol Aging"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/exnr.1995.1093","article-title":"Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease","volume":"136","author":"LA Farrer","year":"1995","journal-title":"Exp Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s004010050824","article-title":"Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease","volume":"95","author":"K Wakabayashi","year":"1998","journal-title":"Acta Neuropathol"},{"key":"ref15","first-page":"24","article-title":"Caspase-cleaved TAR DNA-binding protein-43 in Pick's disease","volume":"1","author":"TT Rohn","year":"2009","journal-title":"Int J Physio Pathophysio Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease","volume":"100","author":"TC Gamblin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nurt.2008.05.006","article-title":"Tau-based treatment strategies in neurodegenerative diseases","volume":"5","author":"A Schneider","year":"2008","journal-title":"Neurotherapeutics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e20495","DOI":"10.1371\/journal.pone.0020495","article-title":"Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain","volume":"6","author":"TT Rohn","year":"2011","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0080180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:19:30Z","timestamp":1647605970000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0080180"}},"subtitle":[],"editor":[{"given":"Chad A.","family":"Dickey","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,2]]},"references-count":18,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0080180","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,2]]}}}